KORU Medical Systems (KRMD) Net Income towards Common Stockholders (2010 - 2026)
KORU Medical Systems (KRMD) posted quarterly Net Income towards Common Stockholders of -$807078.0 for Q1 2026, up 30.8% year-over-year from -$617049.1 in Q1 2025, and up 20.43% quarter-over-quarter from -$1.0 million in Q4 2025.
KORU Medical Systems (KRMD) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Net Income towards Common Stockholders for 12 consecutive years, with -$807078.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 30.8% year-over-year to -$807078.0; the TTM figure through Mar 2026 stood at -$2.8 million (up 46.99% YoY), while the FY2025 annual figure was -$3.2 million, up 47.77% from the prior year.
- Net Income towards Common Stockholders grew to -$807078.0 in Q1 2026 per KRMD's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$206867.0 in Q2 2025 and bottomed at -$6.2 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$2.0 million across 5 years, with a median of -$1.6 million in 2024.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 159.78% — and 2025, when it jumped 79.08%.
- KORU Medical Systems' Net Income towards Common Stockholders stood at -$6.2 million in 2022, then grew by 10.94% to -$5.6 million in 2023, then surged by 71.93% to -$1.6 million in 2024, then surged by 34.91% to -$1.0 million in 2025, then climbed by 20.43% to -$807078.0 in 2026.
- Business Quant data shows KRMD's Net Income towards Common Stockholders at -$807078.0 in Q1 2026, -$1.0 million in Q4 2025, and -$777966.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | KORU Medical Systems | 149.08 Mn | 140.78 Mn | 7.85 Mn | 252,449.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 252,449.00 |
| Mar 31, 2026 | -807,078.00 |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -777,966.00 |
| Jun 30, 2025 | -206,867.00 |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -988,715.00 |
| Mar 31, 2024 | -1.94 Mn |
| Dec 31, 2023 | -5.55 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | -2.41 Mn |
| Dec 31, 2022 | -6.23 Mn |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -2.92 Mn |
| Mar 31, 2022 | -2.54 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | -1.09 Mn |